evidencegaps
Primary study · included by 1 review

Toripalimab combined with docetaxel and cisplatin neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: a single-center, single-arm clinical trial (ESONICT-2).

Gao 2022 · Gao Lei, Lu Jieming, Zhang Peipei, et al. · Journal of gastrointestinal oncology · 2022

Included by

The Efficacy and Safety of Neoadjuvant Immunotherapy in Pan-Squamous Cell Carcinomas: A Meta-Analysis of Esophageal, Head and Neck, Cervical, Lung, Cutaneous, and Oral Squamous Cell Carcinomas.
Non-Cochrane · intervention · 2026 · cited as Gao 2022 · Supplementary Table S1; reference list

The review does not say which of its outcomes this study informs.

1 including review in total.